Cost & Access

Semaglutide Patents Start Expiring in 2026: Will Cheaper "Generic Ozempic" Reach Malaysia?

19 August 20266 min read19 August 2026

Editorial article by the Seimbang team — every figure is taken from the sources listed at the end.

"When will Ozempic go generic?" is now one of the most common questions patients ask. The honest answer is: it depends where you live, and for Malaysia the picture is not yet clear. This article explains what has been published about semaglutide patent expiry, what it is likely to mean for prices, and why a product sold online today as "generic semaglutide" is a different — and dangerous — thing.

What is actually expiring, and where

IQVIA's analysis (August 2025) states that semaglutide "will be under patent in many countries until the early 2030s", but that its patent "will expire in several countries starting in 2026", including India, Canada, China, Brazil and Turkey — countries that together make up about 40% of the world's population. IQVIA also notes ambiguity over whether off-patent semaglutide will be classed as a generic or a biosimilar, which affects how quickly products can be approved.

IQVIA reports that around a dozen manufacturers are developing off-patent semaglutide, and that in India off-patent versions are expected within a year of the launches of the branded products.

Will prices fall?

Not immediately, and probably not by as much as many people hope. IQVIA's early expectations are that in Turkey initial prices of off-patent versions will be very similar to the original, with competition emerging only with the second and third entrants and not projected to reduce prices by more than 50%; in India, competitive pricing of the originals may leave little room for discounting.

What this means in Malaysia

We have not found a published date for semaglutide patent expiry in Malaysia, and we are not aware of a generic semaglutide registered with the National Pharmaceutical Regulatory Agency (NPRA) as of August 2026. Whatever happens to patents, two things do not change: any semaglutide product sold in Malaysia must be registered with NPRA, and GLP-1 medicines are Group B poisons under the Poisons Act 1952 — prescription-only.

That matters because "generic semaglutide" is already being advertised online. Those products are not the future generics IQVIA describes; they are the unregulated "compounded alternatives" and "research peptides" that the Malaysian Obesity Society warned about on 6 January 2026 — unknown purity, unknown dose, no manufacturing oversight.

Should you wait for a generic?

That is a decision for you and your doctor, not for a blog. What can be said is that a Malaysian generic has no published date, that early price drops elsewhere are expected to be modest, and that a doctor-supervised programme is available now. If cost is the concern, ask your doctor what the monthly price at each dose stage is and what is included — at Seimbang every dose tier is published in advance, from RM899/month with consultations included.

Frequently asked questions

Is generic Ozempic available in Malaysia?

Not that we are aware of. We have not found an NPRA-registered generic semaglutide as of August 2026, and no published Malaysian patent-expiry date. Products sold online as "generic" or "compounded" semaglutide are unregulated and were the subject of a Malaysian Obesity Society warning in January 2026.

When does the semaglutide patent expire?

It varies by country. IQVIA states semaglutide remains under patent in many countries until the early 2030s, with expiries starting in 2026 in India, Canada, China, Brazil and Turkey.

Will generic semaglutide make treatment much cheaper?

IQVIA's early expectation is that first off-patent versions will be priced close to the original, with competition arriving with later entrants and reductions not projected to exceed about 50% in the markets it examined. Malaysian pricing will depend on when, and whether, a registered generic arrives.

Sources

Disclaimer: This article summarises published third-party analysis and news reports cited above; patent and regulatory positions change and we do not give legal advice. GLP-1 medication requires a prescription from a registered Malaysian doctor.

Want to know what treatment costs today?

Every Seimbang dose tier is published in advance. A doctor assesses your eligibility first.

See pricing

5 min read